NLM Logo

trilaciclib MeSH Supplementary Concept Data 2025


MeSH Supplementary
trilaciclib
Unique ID
C000708352
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C000708352
Entry Term(s)
2'-((5-(4-Methyl-1-piperazinyl)-2-pyridinyl)amino)-7',8'-dihydro-6'H-spiro(cyclohexane-1,9'-pyrazino(1',2':1,5)pyrrolo(2,3-d)pyrimidin)-6'-one
Spiro(cyclohexane-1,9'(6'H)-pyrazino(1',2':1,5)pyrrolo(2,3-d)pyrimidin)-6'-one, 7',8'-dihydro-2'-((5-(4-methyl-1-piperazinyl)-2-pyridinyl)amino)-
cosela
Registry Numbers
U6072DO9XG
Heading Mapped to
*Pyrimidines
*Pyrroles
Frequency
17
Note
cell-cycle inhibitor; FDA approved to mitigate chemotherapy-induced myelosuppression in adult patients with small cell lung cancer.
Source
Lancet Oncol. 2019 Nov;20(11):1587-1601.
Date of Entry
2020/07/07
Revision Date
2021/07/14
trilaciclib Preferred
2'-((5-(4-Methyl-1-piperazinyl)-2-pyridinyl)amino)-7',8'-dihydro-6'H-spiro(cyclohexane-1,9'-pyrazino(1',2':1,5)pyrrolo(2,3-d)pyrimidin)-6'-one Broader
cosela Narrower
page delivered in 0.006s